This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store.Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.

Lanreotide Ipsen Syringe: Key Features

Acromegaly / Neuroendocrine Tumours (NETs) Video
00:51

Learn about the key features of the Lanreotide Ipsen Syringe in this brief video.

LAN-UK-000489 | November 2024

Explore more Acromegaly / Neuroendocrine Tumours (NETs) Resources

Explore more Acromegaly / Neuroendocrine Tumours (NETs) Resources

Browse